Clinical heterogeneity and ECT in patients with clozapine resistant schizophrenia
Schizophrenia Research · 2024
DOI: 10.1016/j.schres.2024.08.002 ↗Kurz gefasst
Leserbrief in der Zeitschrift Schizophrenia Research, 2024. Verfasst von Matej Markota und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA. Electronic address: markota.matej@mayo.edu. Hauptthemen laut MEDLINE: Electroconvulsive Therapy, Clozapine, Antipsychotic Agents, Schizophrenia, Treatment-Resistant. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA. Electronic address: markota.matej@mayo.edu.
- Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA.
- Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
- Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.
Zitieren
APA
Markota, M., Croarkin, P. E., Coombes, B. J., Gentry, M. T., & Leung, J. G. (2024). Clinical heterogeneity and ECT in patients with clozapine resistant schizophrenia. Schizophrenia Research. https://doi.org/10.1016/j.schres.2024.08.002
Vancouver
Markota M, Croarkin PE, Coombes BJ, Gentry MT, Leung JG. Clinical heterogeneity and ECT in patients with clozapine resistant schizophrenia. Schizophrenia Research. 2024. doi:10.1016/j.schres.2024.08.002
BibTeX
@article{Markota2024,
author = {Markota, Matej and Croarkin, Paul E and Coombes, Brandon J and Gentry, Melanie T and Leung, Jonathan G},
title = {Clinical heterogeneity and ECT in patients with clozapine resistant schizophrenia},
journal = {Schizophrenia Research},
year = {2024},
doi = {10.1016/j.schres.2024.08.002}
}
EUVIMED